Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-08

Clinical Trial Update: Renal Effects of Levosimendan in Cardiac Surgery Patients

View source ↗

Summary

A completed trial assessing renal effects of levosimendan in patients undergoing cardiac surgery, sponsored by Charité University, Berlin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery | Status: COMPLETED